Research & Reports
2026
The Role of Digital Tools and Their Implementation Within Patient Care Pathways for Rare Brain Disorders: The Case of Phenylketonuria
European Journal of Neurology
Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care
European Psychiatry
2025
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria
BMC Health Services Research
2024
Quantifying the economic value of earlier and enhanced management of anorexia nervosa for adults in England, Germany and Spain: improving the care pathway
European Psychiatry
2023
Patient pathways for rare diseases in Europe: ataxia as an example
Orphanet Journal of Rare Diseases
Impact of specialist ataxia centres on health service resource utilisation and costs across Europe: cross-sectional survey
Orphanet Journal of Rare Diseases
Autism with co-occurring epilepsy care pathway in Europe
European Psychiatry
Rethinking the detection and diagnosis of Alzheimer’s disease: Outcomes of a European Brain Council project
Aging Brain
Global synergistic actions to improve brain health for human development
Nature Reviews Neurology
Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy
Journal of Autism and Developmental Disorders
Economic impact of reducing treatment gaps in depression
European Psychiatry
Care pathways for people with major depressive disorder: A European Brain Council Value of Treatment study
European Psychiatry
The effects of COVID-19 on European healthcare provision for working-age adults with major depressive disorder
European Psychiatry
Autism care pathway in Europe
European Psychiatry
Economic analysis of early intervention for autistic children: findings from four case studies in England, Ireland, Italy, and Spain
European Psychiatry
Viewpoint: Assessing the value of mental health treatments in Europe
European Psychiatry2022
2021
Future of the aging brain: Bridging the gap between research and policy
Aging Brain
Labels Matter: Is it Stress or is it Trauma?
Translational Psychiatry
2020
The Value of Early Coordinated Care for Patients Affected by Rare Neurological Diseases Study
(Value Proposition)
2019
EM en Europa: el valor de la integración y la personalización en salud y approximaciones a la atención social
SumEMos para normalizar la vida con EMEn Español
MS in Europe: the value of integrated and personalised health and social care approaches
SumEMos para normalizar la vida con EMIn English
Nutritional Psychiatry: Towards Improving Mental Health by What You Eat
European Neuropsychopharmacology
The Contribution of Invertebrates to the Understanding of the Vertebrate Nervous System, its Mechanisms, Functions and Pathological Dysfunctions
2017
The Value of Treatment for Brain Disorders
(Discussion Paper 2)
2016
The Value of Treatment for Brain Disorders
(Discussion Paper 1)
Archive
Cost and impact of non-treating severe mental illnesses (SMIs): The case study of schizophrenia
(2015)
The economic cost of brain disorders in Europe
European Journal of Neurology (2012)
Cost of Disorders of the Brain in Finland
Duodecim (2014) - in Finnish
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010
Swiss Medical Weekly (2013)
Cost of Disorders of the Brain in the Czech Republic
Časopis Česká a slovenská neurologie a neurochirurgie (2013) - in Czech
The size, burden and cost of disorders of the brain in the UK
Journal of Psychopharmacology (2013)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
European Neuropsychopharmacology (2011)
Cost of disorders of the brain in Europe 2010
European Neuropsychopharmacology (2011)
Resource allocation to brain research in Europe – a full report
European Journal of Neuroscience (2006)
Costs of Disorders of the Brain in Europe
European Journal of Neurology (2005)